[{"_id":"551f89b631cae9239deb1ed1","会社名":"アステラス製薬(株)【4503】","証券コード":"4503","決算期":"2014年3月期","会計方式":"IFRS基準","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"1,139,909百万円","営業利益":"116,806百万円","経常利益":"121,975百万円","当期利益":"90,874百万円","EPS（一株当たり利益）":"40.45円","調整一株当たり利益":"40.39円","BPS（一株当たり純資産）":"568.53円","総資産":"1,653,108百万円","自己資本":"1,268,476百万円","資本金":"103,001百万円","有利子負債":"---","自己資本比率":"76.7%","ROA（総資産利益率）":"5.87%","ROE（自己資本利益率）":"7.81%","総資産経常利益率":"7.87%","__v":0,"日付":"2015-04-04T06:50:30.189Z"},{"_id":"551f89b631cae9239deb1ed2","会社名":"アステラス製薬(株)【4503】","証券コード":"4503","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"1,005,611百万円","営業利益":"153,867百万円","経常利益":"157,156百万円","当期利益":"82,851百万円","EPS（一株当たり利益）":"180.40円","調整一株当たり利益":"180.15円","BPS（一株当たり純資産）":"2,349.61円","総資産":"1,445,561百万円","自己資本":"1,060,089百万円","資本金":"103,000百万円","有利子負債":"---","自己資本比率":"73.3%","ROA（総資産利益率）":"5.82%","ROE（自己資本利益率）":"7.98%","総資産経常利益率":"11.04%","__v":0,"日付":"2015-04-04T06:50:30.190Z"},{"_id":"551f89b631cae9239deb1ed3","会社名":"アステラス製薬(株)【4503】","証券コード":"4503","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月10日","決算月数":"12か月","売上高":"969,387百万円","営業利益":"131,519百万円","経常利益":"135,107百万円","当期利益":"78,230百万円","EPS（一株当たり利益）":"169.38円","調整一株当たり利益":"169.17円","BPS（一株当たり純資産）":"2,200.64円","総資産":"1,400,629百万円","自己資本":"1,016,519百万円","資本金":"103,000百万円","有利子負債":"---","自己資本比率":"72.6%","ROA（総資産利益率）":"5.72%","ROE（自己資本利益率）":"7.68%","総資産経常利益率":"9.88%","__v":0,"日付":"2015-04-04T06:50:30.190Z"}]